nach oben

Erschienen in:

01.08.2015 | Review Article

Staged resection of bilobar colorectal liver metastases: surgical strategies

verfasst von: Cui Yang, Nuh N. Rahbari, Sören Torge Mees, Felix Schaab, Moritz Koch, Jürgen Weitz, Christoph Reissfelder

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Radical resection is the treatment of choice for colorectal liver metastases (CLM). Unfortunately, only about 20 % of patients present with initially resectable disease, in most cases due to bilobar disease. In the last two decades, major achievements have been made to extend surgical indications to patients with bilobar CLM, such as two-stage hepatectomy with or without portal vein occlusion and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS).

Purpose

The purpose of this review article was to summarize current surgical approaches and their safety and efficacy for patients with initially unresectable bilobar CLM.

Conclusion

In selected patients, two-stage hepatectomy and ALPPS are efficient and safe to convert unresectable to resectable CLM. Further studies are required to evaluate long-term outcome of these procedures.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108.CrossRefPubMed

Steele G, Ravikumar TS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210(2):127–138PubMedCentralCrossRefPubMed

Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey J-N (2007) New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res GCR 1(1):20–27PubMed

Lam VWT, Laurence JM, Johnston E, Hollands MJ, Pleass HCC, Richardson AJ (2013) A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB 15(7):483–491PubMedCentralCrossRefPubMed

Abdalla EK, Vauthey J-N, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818–825, discussion 825–827 PubMedCentralCrossRefPubMed

Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E, Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17(10):1225–1239PubMedCentralCrossRefPubMed

Aloia TA, Vauthey J-N (2011) Management of colorectal liver metastases: past, present, and future. Updat Surg 63(1):1–3CrossRef

Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1261–1268CrossRefPubMed

Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231(4):487–499PubMedCentralCrossRefPubMed

10.

Reissfelder C, Rahbari NN, Bejarano LU, Schmidt T, Kortes N, Kauczor H-U, Büchler MW, Weitz J, Koch M (2014) Comparison of various surgical approaches for extensive bilateral colorectal liver metastases. Langenbecks Arch Surg Dtsch Ges Für Chir 399(4):481–491CrossRef

11.

Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232(6):777–785PubMedCentralCrossRefPubMed

12.

Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D, Adam R, Azoulay D (2010) Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 97(2):240–250CrossRefPubMed

13.

Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Matsubara T, Takahashi T, Nakajima T, Muto T (2001) Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181(2):153–159CrossRefPubMed

14.

Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D’Angelica M (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247(1):109–117CrossRefPubMed

15.

Ritz J-P, Lehmann KS, Isbert C, Reissfelder C, Albrecht T, Stein T, Buhr HJ (2006) In-vivo evaluation of a novel bipolar radiofrequency device for interstitial thermotherapy of liver tumors during normal and interrupted hepatic perfusion. J Surg Res 133(2):176–184CrossRefPubMed

16.

Lee H, Heo JS, Cho YB, Yun SH, Kim HC, Lee WY, Choi SH, Choi DW (2015) Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis. World J Gastroenterol WJG 21(11):3300–3307PubMed

17.

Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10(5):803–808CrossRefPubMed

18.

de Baere T, Denys A, Madoff DC (2007) Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 10(1):67–78CrossRefPubMed

19.

Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, Vauthey J-N (2008) Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery 144(5):744–751CrossRefPubMed

20.

Madoff DC, Abdalla EK, Gupta S, Wu T-T, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey J-N (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol JVIR 16(2 Pt 1):215–225CrossRefPubMed

21.

Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey J-N (2003) Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness—study in 26 patients. Radiology 227(1):251–260CrossRefPubMed

22.

Mise Y, Aloia TA, Conrad C, Huang SY, Wallace MJ, Vauthey J-N (2015) Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg Off J Soc Surg Aliment Tract 19(1):133–141CrossRef

23.

Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey J-N (2011) High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol Off J Am Soc Clin Oncol 29(8):1083–1090CrossRef

24.

Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber J-C, Bachellier P (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240(6):1037–1049, discussion 1049–1051 PubMedCentralCrossRefPubMed

25.

Tsim N, Healey AJ, Frampton AE, Habib NA, Bansi DS, Wasan H, Cleator SJ, Stebbing J, Lowdell CP, Jackson JE, Tait P, Jiao LR (2011) Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Ann Surg Oncol 18(7):1939–1946CrossRefPubMed

26.

Jamal MH, Hassanain M, Chaudhury P, Tran TT, Wong S, Yousef Y, Jozaghi Y, Salman A, Jabbour S, Simoneau E, Al-Abbad S, Al-Jiffry M, Arena G, Kavan P, Metrakos P (2012) Staged hepatectomy for bilobar colorectal hepatic metastases. HPB 14(11):782–789PubMedCentralCrossRefPubMed

27.

Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, Marzano E, Bachellier P (2011) Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg 98(10):1463–1475CrossRefPubMed

28.

Elias D, De Baere T, Roche A, null Mducreux, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86(6):784–788CrossRefPubMed

29.

Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatol Baltim Md 34(2):267–272CrossRef

30.

Seymour K, Manas D, Charnley RM (1999) During liver regeneration following right portal vein embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86(11):1482–1483PubMed

31.

Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR (2009) Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 100(4):617–622PubMedCentralCrossRefPubMed

32.

Fischer C, Melstrom LG, Arnaoutakis D, Jarnagin W, Brown K, D’Angelica M, Covey A, DeMatteo R, Allen P, Kingham TP, Tuorto S, Kemeny N, Fong Y (2013) Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg 148(12):1103–1108CrossRefPubMed

33.

Hoekstra LT, van Lienden KP, Doets A, Busch ORC, Gouma DJ, van Gulik TM (2012) Tumor progression after preoperative portal vein embolization. Ann Surg 256(5):812–817, discussion 817–818 CrossRefPubMed

34.

van Gulik TM, van den Esschert JW, de Graaf W, van Lienden KP, Busch ORC, Heger M, van Delden OM, Laméris JS, Gouma DJ (2008) Controversies in the use of portal vein embolization. Dig Surg 25(6):436–444CrossRefPubMed

35.

Beal IK, Anthony S, Papadopoulou A, Hutchins R, Fusai G, Begent R, Davies N, Tibballs J, Davidson B (2006) Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 79(942):473–478CrossRefPubMed

36.

Goéré D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J (2006) Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg Off J Soc Surg Aliment Tract 10(3):365–370CrossRef

37.

Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D’Angelica M, Getrajdman GI, DeMatteo R, Kemeny NE, Fong Y (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247(3):451–455CrossRefPubMed

38.

Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey J-N (2013) Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216(2):201–209PubMedCentralCrossRefPubMed

39.

Reissfelder C, Rahbari NN, Koch M, Kofler B, Sutedja N, Elbers H, Büchler MW, Weitz J (2011) Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg 98(6):836–844CrossRefPubMed

40.

Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J (2008) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg Off J Soc Surg Aliment Tract 12(2):297–303CrossRef

41.

Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197(1):164–170CrossRefPubMed

42.

Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg Off J Soc Surg Aliment Tract 6(6):905–913, discussion 913 CrossRef

43.

Robles R, Marín C, Lopez-Conesa A, Capel A, Perez-Flores D, Parrilla P (2012) Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38(7):586–593

44.

Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC (2008) Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 247(5):825–834CrossRefPubMed

45.

Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414CrossRefPubMed

46.

Alvarez FA, Ardiles V, de Santibañes M, Pekolj J, de Santibañes E (2015) Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg 261:723–32CrossRefPubMed

47.

Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, Cipriani F, Bonariol L, Bassi N, Aldrighetti L, Jovine E (2015) Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS and conventional two-stage hepatectomy. Ann Surg Oncol 22:1933–42CrossRefPubMed

48.

Clark ME, Smith RR (2014) Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol 5(5):374–387PubMedCentralPubMed

49.

Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, Soubrane O, Schnitzbauer AA, Raptis D, Tschuor C, Petrowsky H, De Santibanes E, Clavien P-A, ALPPS Registry Group (2014) Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg 260(5):829–836, discussion 836–838 CrossRefPubMed

50.

Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey J-N (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237(5):686–691, discussion 691–693 PubMedCentralPubMed

51.

Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA (2013) In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 100(3):388–394CrossRefPubMed

52.

Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y (2000) Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 127(2):155–160CrossRefPubMed

53.

Torres OJM, de S. M. Fernandes E, Oliveira CVC, Lima CX, Waechter FL, Moraes-Junior JMA, Linhares MM, Pinto RD, Herman P, Machado MAC (2013) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience. Arq Bras Cir Dig ABCD Braz Arch Dig Surg 26(1):40–43CrossRef

54.

Petrowsky H (2015) Is partial-ALPPS safer than ALPPS? a single-center experience. Ann Surg 2015:2015

55.

Turrini O, Ewald J, Viret F, Sarran A, Goncalves A, Delpero J-R (2012) Two-stage hepatectomy: who will not jump over the second hurdle? Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38(3):266–273

56.

Muratore A, Zimmitti G, Ribero D, Mellano A, Viganò L, Capussotti L (2012) Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it? Ann Surg Oncol 19(4):1310–1315CrossRefPubMed

57.

Bowers KA, O’Reilly D, Bond-Smith GE, Hutchins RR (2012) Feasibility study of two-stage hepatectomy for bilobar liver metastases. Am J Surg 203(6):691–697CrossRefPubMed

58.

Tsai S, Marques HP, de Jong MC, Mira P, Ribeiro V, Choti MA, Schulick RD, Barroso E, Pawlik TM (2010) Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB 12(4):262–269PubMedCentralCrossRefPubMed

59.

Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S (2007) Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 33(3):329–335

60.

Nadalin S, Capobianco I, Li J, Girotti P, Königsrainer I, Königsrainer A (2014) Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre. Z Für Gastroenterol 52(1):35–42CrossRef

61.

Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D, Adam R (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol Off J Am Soc Clin Oncol 24(31):4983–4990CrossRef

62.

Abdalla EK, Vauthey J-N (2008) Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg 25(6):421–429CrossRefPubMed

63.

Reissfelder C, Brand K, Sobiegalla J, Rahbari NN, Bork U, Schirmacher P, Büchler MW, Weitz J, Koch M (2014) Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases. Surgery 155(2):245–254CrossRefPubMed

Titel: Staged resection of bilobar colorectal liver metastases: surgical strategies
verfasst von: Cui Yang
Nuh N. Rahbari
Sören Torge Mees
Felix Schaab
Moritz Koch
Jürgen Weitz
Christoph Reissfelder
Publikationsdatum: 01.08.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 6/2015
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-015-1310-2

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Purpose

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma

Transarterial chemoembolization (TACE) for colorectal liver metastases—current status and critical review

Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis

Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins

Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature

The quality of cholecystectomy in Denmark has improved over 6-year period

Update Chirurgie